Marotta said UK Biocentre will continue operating under its own brand and identity. He also highlighted the facility’s location in the UK “Golden Triangle” corridor connecting London, Oxford, and Cambridge, and noted proximity to Azenta’s other UK operations.Marotta emphasized that the UK is a major life sciences hub for genomics, precision medicine, and population studies, supported by public investment and collaboration between public and private sectors. He said UK Biocentre has become a “critical and tr ...